Skip to main content Accessibility help
×
Home
  • Print publication year: 2019
  • Online publication date: March 2019

7 - Medical Issues in Older Adults with Schizophrenia

from Section 2 - Biological, Neurocognitive, and Medical Aspects

Related content

Powered by UNSILO
1.Hendrie, HC, Tu, W, Tabbey, R, et al. Health outcomes and cost of care among older adults with schizophrenia: a 10-year study using medical records across the continuum of care. Am J Geriatr Psychiatry 2014; 22(5): 427–36.
2.Brink, M, Green, A, Bojesen, AB, et al. Physical health, medication, and healthcare utilization among 70–year–old people with schizophrenia: a nationwide Danish register study. Am J Geriatr Psychiatry 2017; 25: 500–9.
3.Talaslahti, T, Alanen, H-M, Hakko, H, et al. Mortality and causes of death in older patients with schizophrenia. Int J Geriatr Psychiatry 2012; 27: 1131–7.
4.Laursen, TM. Life expectancy among persons with schizophrenia or bipolar affective disorder. Schizophr Res 2011; 131(1–3): 101–4.
5.Hjorthøj, C, Stürup, AE, Mcgrath, JJ, Nordentoft, M. Years of potential life lost and life expectancy in schizophrenia: a systematic review and meta-analysis. Lancet Psychiatry 2017; 4(4): 295301.
6.Saha, S, Chant, D, McGrath, J. A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time? Arch Gen Psychiatry 2007; 64: 1123–31.
7.Cohen, CI, Freeman, K, Ghoneim, D, et al. Advances in the conceptualization and study of schizophrenia in later life. Psychiatr Clin N Am 2018; 41: 3953.
8.Almeida, OP, Hankey, GJ, Yeap, BB, et al. Mortality among people with severe mental disorders who reach old age: a longitudinal study of a community-representative sample of 37892 men. PloS one 2014; 9(10): e111882.
9.Meesters, PD, Comijs, HC, Smit, JH, et al. Mortality and its determinants in late-life schizophrenia: a 5-year prospective study in a Dutch catchment area. Am J Geriatr Psychiatry 2016; 24: 272–7.
10.Hoang, U, Stewart, R, Goldacre, MJ. Mortality after hospital discharge for people with schizophrenia or bipolar disorder: retrospective study of linked English hospital episode statistics, 1999–2006. BMJ 2011; 343: d5422.
11.Erlangsen, A, Eaton, WW, Mortensen, PB, Conwell, Y. Schizophrenia: a predictor of suicide during the second half of life? Schizophr Res 2012; 134(2–3): 111–17.
12.Chang, CK, Hayes, RD, Broadbent, M, et al. All-cause mortality among people with serious mental illness (SMI), substance use disorders, and depressive disorders in southeast London: a cohort study. BMC Psychiatry 2010; 10: 77.
13.Meesters, PD. Healthy older schizophrenia patients: exceptions to the rule? Am J Geriatr Psychiatry 2017; 25(5): 510–11.
14.Crump, C, Winkleby, MA, Sundquist, K, Sundquist, J. Comorbidities and mortality in persons with schizophrenia: a Swedish national cohort study. Am J Psychiatry 2013; 170(3): 324–33.
15.Partti, K, Vasankari, T, Kanervisto, M, et al. Lung function and respiratory diseases in people with psychosis: population-based study. Br J Psychiatry 2015; 207(1): 3745.
16.Kredentser, MS, Martens, PJ, Chochinov, HM, Prior, HJ. Cause and rate of death in people with schizophrenia across the lifespan: a population-based study in Manitoba, Canada. J Clin Psychiatry 2012; 74: 154–61.
17.Talaslahti, T, Alanen, HM, Hakko, H, et al. Patients with very‐late‐onset schizophrenia‐like psychosis have higher mortality rates than elderly patients with earlier onset schizophrenia. Int J Geriatr Psychiatry 2015; 30(5): 453–9.
18.Hsu, J-H, Chien, IC, Lin, CH, Chou, YJ, Chou, P. Increased risk of chronic obstructive pulmonary disease in patients with schizophrenia: a population-based study. Psychosomatics 2013; 54(4): 345–51.
19.Schoepf, D, Uppal, H, Potluri, R, Heun, R. Physical comorbidity and its relevance on mortality in schizophrenia: a naturalistic 12-year follow-up in general hospital admissions. Eur Arch Psychiatry Clin Neurosci 2014; 264(1): 328.
20.Bouza, C, López-Cuadrado, T, María Amate, J. Physical disease in schizophrenia: a population-based analysis in Spain. BMC Publ Health 2010; 10(1): 745.
21.Cahoon, EK, McGinty, EE, Ford, DE, Daumit, GL. Schizophrenia and potentially preventable hospitalizations in the United States: a retrospective cross-sectional study. BMC Psychiatry 2013; 13(1): 37.
22.Olfson, M, Gerhard, T, Huang, C, Crystal, S, Stroup, TS. Premature mortality among adults with schizophrenia in the United States. JAMA Psychiatry 2015; 72(12): 1172–81.
23.Chen, Y-H, Lin, H-C, Lin, H-C. Poor clinical outcomes among pneumonia patients with schizophrenia. Schizophr Bull 2010; 37(5): 1088–94.
24.Chou, FH-C, Tsai, K-Y, Chou, Y-M. The incidence and all-cause mortality of pneumonia in patients with schizophrenia: a nine-year follow-up study. J Psychiatr Res 2013; 47(4): 460–6.
25.U.S. Food and Drug Administration. Public Health Advisory: Deaths with Antipsychotics in Elderly Patients with Behavioural Disturbances. Silver Spring, MD: U.S. Food and Drug Administration; 2005.
26.Trifirò, G, Gambassi, G, Sen, EF, et al. Association of community-acquired pneumonia with antipsychotic drug use in elderly patients: a nested case-control study. Ann Intern Med 2010; 152: 418–25.
27.Knol, W, Marum, RJ, Jansen, PA, et al. Antipsychotic drug use and risk of pneumonia in elderly people. J Am Geriatr Soc 2008; 56: 661–6.
28.Gau, JT, Acharya, U, Khan, S, et al. Pharmacotherapy and the risk for community-acquired pneumonia. BMC Geriatr 2010; 10: 45.
29.Star, K, Bate, A, Meyboom, RH, Edwards, IR. Pneumonia following antipsychotic prescriptions in electronic health records: a patient safety concern? Br J Gen Pract 2010; 60: e385–94.
30.Barnett, MJ, Perry, PJ, Alexander, B, Kaboli, PJ. Risk of mortality associated with antipsychotic and other neuropsychiatric drugs in pneumonia patients. J Clin Psychopharmacol 2006; 26: 182–7.
31.Kuo, C-J, Yang, S-Y, Liao, Y-T, et al. Second-generation antipsychotic medications and risk of pneumonia in schizophrenia. Schizophr Bull 2013; 39(3): 648–57.
32.Trifirò, G. Antipsychotic drug use and community-acquired pneumonia. Curr Infect Disease Rep 2011; 13(3): 262–8.
33.Correll, CU, Detraux, J, De Lepeleire, J, De Hert, M. Effects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder. World Psychiatry 2015; 14(2): 119–36.
34.Vahia, IV, Diwan, S, Bankole, AO, et al. Adequacy of medical treatment among older persons with schizophrenia. Psychiatr Serv 2008; 59: 853–9.
35.Kilbourne, AM, Brar, JS, Drayer, RA, Xu, X, Post, EP. Cardiovascular disease and metabolic risk factors in male patients with schizophrenia, schizoaffective disorder, and bipolar disorder. Psychosomatics 2007; 48(5): 412–17.
36.Sajatovic, M, Gunzler, D, Einstadter, D, et al. A preliminary analysis of individuals with serious mental illness and comorbid diabetes. Arch Psychiatr Nurs 2016; 30(2): 226–9.
37.Osborn, DPJ, Levy, G, Nazareth, I, Petersen, I, Islam, A, King, MB. Relative risk of cardiovascular and cancer mortality in people with severe mental illness from the United Kingdom's General Practice Research Database. Arch Gen Psychiatry 2007; 64(2): 242–9.
38.Casey, DA, Rodriguez, M, Northcott, C, Vickar, G, Shihabuddin, L. Schizophrenia: medical illness, mortality, and aging. Int J Psychiatry Med 2011; 41(3): 245–51.
39.Martens, PJ, Chochinov, HM, Prior, HJ. Where and how people with schizophrenia die: a population-based, matched cohort study in Manitoba, Canada. J Clin Psychiatry 2013; 74(6): e551–7.
40.Jeste, DV, Wolkowitz, OM, Palmer, BW. Divergent trajectories of physical, cognitive, and psychosocial aging in schizophrenia. Schizophr Bull 2011; 37(3): 451–5.
41.Bresee, LC, Majumdar, SR, Patten, SB, et al. Prevalence of cardiovascular risk factors and disease in people with schizophrenia: a population-based study. Schizophr Res 2010; 117: 7582.
42.Hahn, LA, Mackinnon, A, Foley, DL, et al. The value of counting WHO-defined cardiovascular risk factors for death and disability in a national sample of adults with psychosis. Schizophr Res 2017; 182: 1318.
43.Fors, BM, Isacson, D, Bingefors, K, Widerlov, B. Mortality among persons with schizophrenia in Sweden: an epidemiological study. Nord J Psychiatry 2007; 61(4): 252–9.
44.Goff, DC, Cather, C, Evins, AE, et al. Medical morbidity and mortality in schizophrenia: guidelines for psychiatrists. J Clin Psychiatry 2005; 66(2): 183–94.
45.Olfson, M, Gerhard, T, Huang, C, Crystal, S, Stroup, TS. Premature mortality among adults with schizophrenia in the United States. JAMA Psychiatry 2015; 72(12): 1172–81.
46.Ösby, U, Westman, J, Hällgren, J, Gissler, M. Mortality trends in cardiovascular causes in schizophrenia, bipolar and unipolar mood disorder in Sweden 1987–2010. Eur J Publ Health 2016; 26(5): 867–71.
47.Schulman-Marcus, J, Goyal, P, Swaminathan, RV, et al. Comparison of trends in incidence, revascularization, and in-hospital mortality in ST-elevation myocardial infarction in patients with versus without severe mental illness. Am J Cardiol 2016; 117(9): 1405–10.
48.Bodén, R, Molin, E, Jernberg, T, et al. Higher mortality after myocardial infarction in patients with severe mental illness: a nationwide cohort study. J Intern Med 2015; 277(6): 727–36.
49.Viñas, CL, Fernández San-Martín, MI, Martín López, LM. Effectiveness of a joint project between primary care and mental health to improve the recording of cardiovascular risk factors in patients with psychosis. Aten Primaria 2012; 45(6): 307–14.
50.Rouillon, F, Van Ganse, E, Vekhoff, P, et al. Vigilance level for cardiovascular risk factors in schizophrenic patients. L'Encephale 2015; 41(1): 70–7.
51.Daumit, GL, Goff, DC, Meyer, JM, et al. Antipsychotic effects on estimated 10-year coronary heart disease risk in the CATIE schizophrenia study. Schizophr Res 2008; 105(1–3): 174–87.
52.Torniainen, M, Mittendorfer-Rutz, E, Tanskanen, A, et al. Antipsychotic treatment and mortality in schizophrenia. Schizophr Bull 2015; 41(3): 656–63.
53.Zhou, C, Tao, R, Jiang, R, Lin, X, Shao, M. Cancer mortality in patients with schizophrenia: systematic review and meta-analysis. Br J Psychiatry 2017; 211(1): 713.
54.Talaslahti, T. Finnish older patients with schizophrenia: antipsychotic use, psychiatric admissions, long-term care and mortality. Dissertation, University of Tampere, 2015.
55.Kelly, DL, McMahon, RP, Wehring, HJ, et al. Cigarette smoking and mortality risk in people with schizophrenia. Schizophr Bull 2011; 37(4): 832–8.
56.Das-Munshi, J, Chang, CK, Dutta, R, et al. Ethnicity and excess mortality in severe mental illness: a cohort study. Lancet Psychiatry 2017; 4(5): 389–99.
57.Kisely, S, Sadek, J, Mackenzie, A, Lawrence, D, Campbell, LA. Excess cancer mortality in psychiatric patients. Can J Psychiatry 2008; 53: 753–61.
58.Kisely, S, Crowe, E, Lawrence, D. Cancer-related mortality in people with mental illness. JAMA Psychiatry 2013; 70(2): 209–17.
59.Lawrence, D, Holman, CD, Jablensky, AV, Threlfall, TJ, Fuller, SA. Excess cancer mortality in Western Australian psychiatric patients due to higher case fatality rates. Acta Psychiatr Scand 2000; 101(5): 382–8.
60.Bushe, CJ, Hodgson, R. Schizophrenia and cancer: in 2010 do we understand the connection? Can J Psychiatry 2010; 55(12): 761–7.
61.Goldacre, MJ, Kurina, LM, Wotton, CJ, Yeates, D, Seagroat, V. Schizophrenia and cancer: an epidemiological study. Br J Psychiatry 2005; 187: 334–8.
62.Chen, LY, Hung, YN, Chen, YY, et al. Cancer incidence in young and middle-aged people with schizophrenia: nationwide cohort study in Taiwan, 2000–2010. Epidemiol Psychiatr Sci 2018; 27(2): 146–56.
63.Lin, G-M, Chen, YJ, Kuo, DJ, et al. Cancer incidence in patients with schizophrenia or bipolar disorder: a nationwide population-based study in Taiwan, 1997–2009. Schizophr Bull 2013; 39(2): 407–16.
64.Kisely, S, Forsyth, S, Lawrence, D. Why do psychiatric patients have higher cancer mortality rates when cancer incidence is the same or lower? Aus NZ J Psychiatry 2016; 50(3): 254–63.
65.Lin, C‐Y, Lane, HY, Chen, TT, et al. Inverse association between cancer risks and age in schizophrenic patients: a 12‐year nationwide cohort study. Cancer Sci 2013; 104(3): 383–90.
66.Bergamo, C, Sigel, K, Mhango, G, Kale, M, Wisnivesky, JP. Inequalities in lung cancer care of elderly patients with schizophrenia: an observational cohort study. Psychosom Med 2014; 76(3): 215.
67.Baillargeon, J, Kuo, YF, Lin, YL, et al. Effect of mental disorders on diagnosis, treatment, and survival of older adults with colon cancer. J Am Geriatr Soc 2011; 59(7): 1268–73.
68.Werneke, U, Horn, O, Maryon-Davis, A, et al. Uptake of screening for breast cancer in patients with mental health problems. J Epidemiol Community Health 2006; 60(7): 600–5.
69.Irwin, KE, Henderson, DC, Knight, HP, Pirl, WF. Cancer care for individuals with schizophrenia. Cancer 2014; 120(3): 323–34.
70.Aggarwal, A, Pandurangi, A, Smith, W. Disparities in breast and cervical cancer screening in women with mental illness: a systematic literature review. Am J Prev Med 2013; 44(4): 392–8.
71.Chochinov, H, Martena, PJ, Prior, HJ, Fransoo, R, Burland, E. Does a diagnosis of schizophrenia reduce rates of mammography screening? A Manitoba population-based study. Schizophr Res 2009; 113: 95100.
72.Xiong, G, Bermudes, R, Torres, S, Hales, R. Use of cancer screening services among patients with serious mental illness in Sacramento County. Psychiatr Serv 2008; 59: 929–32.
73.Martens, PJ, Chochinov, HM, Prior, HJ, et al. Are cervical cancer screening rates different for women with schizophrenia? A Manitoba population-based study. Schizophr Res 2009; 113(1): 101–6.
74.Crump, C, Winkleby, MA, Sundquist, K, Sundquist, J. Comorbidities and mortality in persons with schizophrenia: a Swedish national cohort study. Am J Psychiatry 2013; 170: 324–33.
75.De Hert, M, Peuskens, J, Sabbe, T, et al. Relationship between prolactin, breast cancer risk and antipsychotics in patients with schizophrenia: a critical review. Acta Psychiatr Scand 2016; 133(1): 522.
76.Andrews, AO, Bartels, SJ, Xie, H, et al. Increased risk of nursing home admission among middle aged and older adults with schizophrenia. Am J Geriatr Psychiatry 2009; 17(8): 697705.
77.Horan, ME, Muller, JJ, Winocur, S, et al. Quality of life in boarding houses and hostels: a residents’ perspective. Community Ment Health J 2001; 37(4): 323–34.
78.Davis, CL, Kilbourne, AM, Blow, FC, et al. Reduced mortality among Department of Veterans Affairs patients with schizophrenia or bipolar disorder lost to follow-up and engaged in active outreach to return for care. Am J Publ Health 2012; 102(Suppl 1): S74–9.
79.Ganzini, L, Socherman, R, Duckart, J, Shores, M. End-of-life care for veterans with schizophrenia and cancer. Psychiatr Serv 2010; 61: 725–8.
80.Bartels, SJ, DiMilia, PR, Fortuna, KL, Naslund, JA. Integrated care for older adults with serious mental illness and medical comorbidity: evidence-based models and future research directions. Psychiatr Clin N Am 2018; 41(1): 153–64.
81.Druss, BG, Rohrbaugh, RM, Levinson, CM, et al. Integrated medical care for patients with serious psychiatric illness: a randomized trial. Arch Gen Psychiatry 2001; 58(9): 861–8.
82.Saxon, AJ, Malte, CA, Sloan, KL, et al. Randomized trial of onsite versus referral primary medical care for veterans in addictions treatment. Med Care 2006; 44(4): 334–42.
83.Druss, BG. Improving medical care for persons with serious mental illness: challenges and solutions. J Clin Psychiatry 2007; 68(Suppl 4): 40–4.
84.Druss, BG, von Esenwein, SA, Compton, MT, et al. A randomized trial of medical care management for community mental health settings: the primary care access, referral, and evaluation (PCARE) study. Am J Psychiatry 2010; 167(2): 151–9.
85.Druss, BG, von Esenwein, SA, Glick, GE, et al. Randomized trial of an integrated behavioral health home: the health outcomes management and evaluation (HOME) study. Am J Psychiatry 2017; 174(3): 246–55.
86.Pirraglia, PA, Rowland, E, Wu, W-C, et al. Benefits of a primary care clinic co-located and integrated in a mental health setting for veterans with serious mental illness. Prev Chronic Dis 2012; 9: E51.
87.Pratt, SI, Bartels, SJ, Mueser, KT, et al. Feasibility and effectiveness of an automated telehealth intervention to improve illness self-management in people with serious psychiatric and medical disorders. Psychiatr Rehabil J 2013; 36(4): 297305.
88.Fortuna, KL, Dimilia, PR, Lohman, MC, et al. Feasibility, acceptability, and preliminary effectiveness of a peer-delivered and technology supported self-management intervention for older adults with serious mental illness. Psychiatr Q. 2018; 89(2): 293305.
89.Naslund, JA, Aschbrenner, KA, Bartels, SJ. How people living with serious mental illness use smartphones, mobile apps, and social media. Psychiatr Rehabil J 2016; 39(4): 364–7.
90.Naslund, JA, Aschbrenner, KA, Marsch, LA, et al. The future of mental health care: peer-to-peer support and social media. Epidemiol Psychiatr Sci 2016; 25(2): 113–22.
91.Naslund, JA, Aschbrenner, KA, McHugo, GJ, et al. Exploring opportunities to support mental health care using social media: a survey of social media users with mental illness. Early Interv Psychiatry 2017: 19. doi: 10.1111/eip.12496. [Epub ahead of print]
92.Fortuna, KL, Lohman, MC, Batsis, JA, et al. Patient experience with healthcare services among older adults with serious mental illness compared to the general older population. Int J Psychiatry Med 2017; 52(4-6): 381–98.
93.De Hert, M, Cohen, D, Bobes, J, et al. Physical illness in patients with severe mental disorders. II. Barriers to care, monitoring and treatment guidelines, plus recommendations at the system and individual level. World Psychiatry 2011; 10(2): 138–51.